300497.SZ
Jiangxi Fushine Pharmaceutical Co Ltd
Price:  
9.99 
CNY
Volume:  
31,959,000.00
China | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

300497.SZ EV/EBITDA

-143.3%
Upside

As of 2025-07-14, the EV/EBITDA ratio of Jiangxi Fushine Pharmaceutical Co Ltd (300497.SZ) is -28.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 300497.SZ's latest enterprise value is 6,891.61 mil CNY. 300497.SZ's TTM EBITDA according to its financial statements is -241.39 mil CNY. Dividing these 2 quantities gives us the above 300497.SZ EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 15.3x - 19.8x 16.4x
Forward P/E multiples 10.1x - 11.3x 11.1x
Fair Price (9.27) - 1.17 (4.32)
Upside -192.8% - -88.3% -143.3%
9.99 CNY
Stock Price
(4.32) CNY
Fair Price

300497.SZ EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-04 -26.70
2025-07-03 -26.95
2025-07-02 -26.48
2025-07-01 -26.64
2025-06-30 -26.27
2025-06-27 -25.75
2025-06-26 -25.66
2025-06-25 -26.04
2025-06-24 -26.32
2025-06-23 -25.84
2025-06-20 -25.59
2025-06-19 -25.63
2025-06-18 -26.43
2025-06-17 -26.70
2025-06-16 -26.98
2025-06-13 -26.84
2025-06-12 -27.34
2025-06-11 -27.32
2025-06-10 -27.62
2025-06-09 -27.43
2025-06-06 -26.91
2025-06-05 -26.98
2025-06-04 -27.25
2025-06-03 -27.59
2025-05-30 -27.52
2025-05-29 -28.18
2025-05-28 -26.34
2025-05-27 -26.68
2025-05-26 -25.22
2025-05-23 -25.72
2025-05-22 -25.13
2025-05-21 -25.38
2025-05-20 -25.70
2025-05-19 -25.34
2025-05-16 -25.45
2025-05-15 -25.11
2025-05-14 -24.86
2025-05-13 -25.09
2025-05-12 -25.13
2025-05-09 -25.22
2025-05-08 -25.68
2025-05-07 -25.56
2025-05-06 -25.70
2025-04-30 -25.02
2025-04-29 -25.04
2025-04-28 -25.45
2025-04-25 -24.88
2025-04-24 -24.70
2025-04-23 -24.70
2025-04-22 -24.93